How should a 16-year-old with a serum potassium of 5.9 mmol/L be evaluated and treated?

Management of a 16-Year-Old with Potassium 5.9 mmol/L

This 16-year-old requires immediate ECG assessment and clinical evaluation for symptoms, followed by acute treatment if ECG changes or symptoms are present, as a potassium of 5.9 mmol/L represents moderate-to-severe hyperkalemia with potential cardiac risk.

Initial Assessment

Rule Out Pseudohyperkalemia First

Before treating, confirm this is true hyperkalemia by:

• Checking if blood draw involved fist clenching, tourniquet use, or hemolysis 1
• Considering repeat measurement in heparin plasma (plasma K+ runs 0.1-0.4 mmol/L lower than serum) 1
• In adolescents, pseudohyperkalemia from poor phlebotomy technique is common

Immediate Clinical Evaluation

Assess for:

• ECG changes: peaked T waves, prolonged QRS complex (though ECG findings are variable and not always sensitive) 1
• Neuromuscular symptoms: muscle weakness, paralysis 2
• Cardiac symptoms: palpitations, arrhythmias

Critical caveat: ECG changes don't always correlate with potassium levels, but their presence mandates urgent treatment 1.

Treatment Algorithm

If ECG Changes or Symptoms Present → Acute Treatment Required

Immediate interventions (in order of priority) 1:

1. IV Calcium gluconate (10 mL of 10%) - Acts within 1-3 minutes to stabilize cardiac membrane; repeat in 5-10 minutes if no effect 1

2. IV Insulin (10 units) + Glucose (50 mL dextrose) - Shifts K+ intracellularly within 30 minutes 1

3. Nebulized salbutamol (20 mg in 4 mL) - Redistributes K+ intracellularly; effect lasts 2-4 hours 1

4. Consider sodium bicarbonate IV - Only if concurrent metabolic acidosis present 1

If No ECG Changes and Asymptomatic → Identify and Address Cause

Investigate underlying etiology:

• Medications: NSAIDs, ACE inhibitors, ARBs, potassium-sparing diuretics, spironolactone (though hyperkalemia is rare in adolescents on spironolactone - only 2.2% incidence) 3
• Renal function: Check creatinine, eGFR
• Dietary intake: Excessive potassium supplements, salt substitutes, potassium additives in processed foods 4
• Endocrine causes: Adrenal insufficiency, hypoaldosteronism
• Tissue breakdown: Rhabdomyolysis, tumor lysis

Monitoring and Follow-Up

• Reassess potassium within 1 week after any intervention 1
• Monitor K+ trajectory and repeat ECG 1
• If on RAASi therapy that's indicated, don't discontinue permanently - hyperkalemia should be treated and RAASi restarted after resolution, as discontinuation increases mortality risk 1

Long-Term Management Considerations

Dietary modification (though evidence shows weak correlation between dietary intake and serum K+ in most patients) 1, 4:

• Limit potassium additives in processed foods
• Moderate portions of high-potassium foods (large servings of meat, milk)
• Maintain high-fiber diet with fruits/vegetables (paradoxically, healthy dietary patterns may support intracellular K+ shifts) 4

Newer potassium binders (patiromer, sodium zirconium cyclosilicate) are available for chronic management if needed, though typically reserved for patients with CKD or heart failure requiring RAASi optimization 1, 2, 5.

Key Clinical Pitfalls

• Don't assume normal K+ is truly normal: In patients with thrombocytosis (>500×10⁹/L), platelets release K+ during clotting, causing falsely elevated serum values - use heparin plasma instead 6
• Don't rigidly follow arbitrary thresholds: Focus on clinical impact (symptoms, ECG changes, rapid fluctuations) rather than just the number 1
• Don't overlook medication review: Many adolescents may be on medications (including spironolactone for gender transition) that affect K+ 3
• Hyperkalemia in adolescents is often transient and asymptomatic when present, but still requires investigation 3